VioQuest Pharmaceuticals (VioQuest Pharmaceuticals) Debt-to-EBITDA : 0.00 (As of Jun. 2008)

VioQuest Pharmaceuticals Debt-to-EBITDA Chart

VioQuest Pharmaceuticals Annual Data
	Trend	Dec98	Dec99	Dec00	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07
Debt-to-EBITDA		Get a 7-Day Free Trial					-	-	-0.03	-0.05	-0.39

VioQuest Pharmaceuticals Quarterly Data
	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.23	-0.30	-0.70	-	-

Competitive Comparison of VioQuest Pharmaceuticals's Debt-to-EBITDA

For the Biotechnology subindustry, VioQuest Pharmaceuticals's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VioQuest Pharmaceuticals's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VioQuest Pharmaceuticals's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where VioQuest Pharmaceuticals's Debt-to-EBITDA falls into.

VioQuest Pharmaceuticals Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

VioQuest Pharmaceuticals's Debt-to-EBITDA for the fiscal year that ended in Dec. 2007 is calculated as

VioQuest Pharmaceuticals's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2008) EBITDA data.

VioQuest Pharmaceuticals  (OTCPK:VOQP) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

VioQuest Pharmaceuticals Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of VioQuest Pharmaceuticals's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

VioQuest Pharmaceuticals (VioQuest Pharmaceuticals) Business Description